** Medical device maker Nevro Corp's shares NVRO.N rise 14.1% to $5.73, while Globus Medical GMED.N shares fall 4.5% to $88.22

** Globus Medical to acquire all shares of Nevro in an all-cash transaction, representing a total equity value of ~$250 million

** Deal offers $5.85 per share for each share of Nevro Corp, a premium of 16.5% to NVRO's last close

** Deal is expected to close late in Q2 2025

** In the last 12 months, GMED up 58.88%, while NVRO has fallen 60.78%

(Reporting by Siddhi Mahatole)

((siddhiprabhanjan.mahatole@thomsonreuters.com))